Company / Tangible Book Value per Share
GT Biopharma, Inc. Tangible Book Value per Share History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$4.70
FY2020
5-year range
-$25.76 / $2415.02
FY2016-FY2020
Trend
-100.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has fluctuated over the past 8 years, ranging from $-25.76 in FY2016 to $2415.02 in FY2017.
Based on SEC 10-K filings.
-4.70 in FY2020.
Improved from $-25.76 to $-4.70 over the past 4 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, tangible book value per share decreased 100.2% year-over-year.
- Peak tangible book value per share was recorded in FY2017.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$4.70 | -100.2% |
| FY2017 | $2415.02 | +9473.6% |
| FY2016 | -$25.76 | -106.2% |
| FY2015 | -$12.50 | -24114.2% |
| FY2014 | -$0.05 | -307.9% |
| FY2013 | -$0.01 | +46.2% |
| FY2012 | -$0.02 | +31.0% |
| FY2011 | -$0.03 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026